The 2024 Women’s Cardiometabolic Health and Wellness Masterclass took place on April 18-20, 2024, at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California. The
CLINICAL BRIEF The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes This clinical brief was developed from a presentation at
Another drug to help patients with obesity-related conditions lose weight has been approved by the U.S. Food and Drug Administration (FDA). The approval of Zepbound
On Saturday, Oct. 21, 2023, Cardiometabolic Health Congress (CMHC) celebrated the final day of its 18th Annual Conference, Social Determinants and Digital Advances in Cardiorenal
The third day of Social Determinants and Digital Advances in Cardiorenal Metabolic Health, the 18th Annual Cardiometabolic Health Congress (CMHC), delivered insights on selecting and
The cardiorenal metabolic education continued on Thursday, Oct. 19, 2023, when the 18th Annual Cardiometabolic Health Congress (CMHC) launched its second day of sessions at
On Wednesday, Oct. 18, 2023, Cardiometabolic Health Congress (CMHC) returned to the Boston Park Plaza for the 18th Annual Conference, Social Determinants and Digital Advances
This clinical brief was developed from a session at the 17th Annual Cardiometabolic Health Congress (CMHC) presented by Irl B Hirsch, MD from the University
This clinical brief was developed by Cardiometabolic Health Congress (CMHC) and supported by an educational grant from Alnylam Pharmaceuticals, Inc. Click Here to claim up
Semaglutide and tirzepatide are some drugs developed for glucose control in diabetes that are now being used to treat obesity.
The 2023 Women’s Cardiometabolic Health and Wellness Masterclass took place on Aug. 17-20, 2023, at the Laguna Cliffs Marriott Resort and Spa in Dana Point,
A view of the Laguna Cliffs property from outside the Women’s Masterclass general sessions Breakfast and Yoga On Saturday, Aug. 20, 2023, the third and
Conference attendees began day two of the Women’s Cardiometabolic Health and Wellness Masterclass with a sunrise yoga class on the lawn of the Laguna Cliffs
The 2023 Women’s Cardiometabolic Health and Wellness Masterclass began on Thursday, Aug. 17 at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California.
Artificial intelligence (AI) is changing patient care, so Cardiometabolic Health Congress (CMHC) sat down with one of the field’s thought leaders, Eric D. Peterson, MD,
This complimentary activity was developed by Neha Agarwal, PhD, Senior Clinical Manager for Cardiometabolic Health Congress (CMHC). It is supported by an educational grant from Lilly
A recent report released by the American Medical Association (AMA) Council on Science and Public Health evaluated the problematic history of using body mass index
The U.S. Food and Drug Administration (FDA) announced on May 26, 2023, it had approved the once-daily oral tablet sotagliflozin to reduce the risk of
An herbal supplement is being promoted on social media as a natural alternative to Wegovy and Ozempic, the brand-name formulations of semaglutide that have made
On Thursday, May 25, 2023, Cardiometabolic Health Congress (CMHC) proudly welcomed Dr. Kris Vijay, president of the Innovative Cardiometabolic Center in Phoenix, to host a
A peer-reviewed study circulated by the Journal of the American Medical Association on Monday, May 22, 2023, took a closer look at study results first
The Spring conference from Cardiometabolic Health Congress (CMHC) continued on Saturday, May 20, 2023, at the Gaylord Palms Resort & Convention Center in Orlando. Taming the
The Spring conference from Cardiometabolic Health Congress (CMHC) began on Friday, May 19, 2023, at the Gaylord Palms Resort & Convention Center in Orlando. Taming the
Colchicine is an anti-inflammatory drug derived from Colchicum autumnale, a toxic autumn-blooming flowering plant commonly known as autumn crocus or meadow saffron. The alkaloid is
Regeneron Pharmaceuticals, Inc. announced on March 22, 2023, that the U.S. Food and Drug Administration (FDA) had extended the approval of Evkeeza® (evinacumab) as an
The experts behind Cardiometabolic Health Congress have identified 10 stories in cardiorenal medicine to watch in 2023.
Results from a new cross-sectional study published in Respiratory Medicine provide evidence that obesity is associated with adverse respiratory symptoms in women, but the same
Compared with their nonpregnant counterparts, pregnant women with COVID-19 experience a more severe disease course with increased rates of intensive care unit admission and need
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, Cardiometabolic Health Congress. All Rights Reserved.
